10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 328 filers reported holding 10X GENOMICS INC in Q3 2021. The put-call ratio across all filers is 2.03 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,124,040 | -26.6% | 172,704 | -0.7% | 0.02% | -18.2% |
| Q2 2023 | $9,707,784 | -4.1% | 173,850 | -4.2% | 0.02% | -12.0% |
| Q1 2023 | $10,119,748 | +53.3% | 181,390 | +0.2% | 0.02% | +47.1% |
| Q4 2022 | $6,599,284 | +24.0% | 181,100 | -3.1% | 0.02% | +13.3% |
| Q3 2022 | $5,321,000 | -37.1% | 186,840 | 0.0% | 0.02% | -31.8% |
| Q2 2022 | $8,455,000 | -50.5% | 186,840 | -16.9% | 0.02% | -43.6% |
| Q1 2022 | $17,097,000 | -48.7% | 224,744 | +0.4% | 0.04% | -43.5% |
| Q4 2021 | $33,358,000 | -6.4% | 223,948 | -8.5% | 0.07% | -10.4% |
| Q3 2021 | $35,621,000 | -27.3% | 244,687 | -2.2% | 0.08% | -26.0% |
| Q2 2021 | $48,992,000 | +619.3% | 250,193 | +563.4% | 0.10% | +593.3% |
| Q1 2021 | $6,811,000 | +11.1% | 37,715 | -12.8% | 0.02% | +25.0% |
| Q4 2020 | $6,128,000 | – | 43,267 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |